Nurse Practitioner Pleads Guilty to Unlawful Drug Distribution

ALBANY, NEW YORK – Christopher Viagrande, age 42, of Latham, New York, pled guilty today to distributing controlled substances outside the course of professional practice and for no legitimate medical purpose.

United States Attorney Carla B. Freedman and Special Agent in Charge Frank A. Tarentino III, U.S. Drug Enforcement Administration (DEA), New York Division, made the announcement.

Viagrande admitted that from May 2021 through January 2024, he issued a total of 149 controlled substance prescriptions, to a total of five people, for no legitimate medical purpose. Viagrande also admitted to improperly issuing an additional 28 controlled substance prescriptions, to two people, from June 2019 to April 2020. Nearly all of the prescriptions were for amphetamine.

Viagrande admitted to prescribing dangerous amounts of amphetamine to someone (identified in court papers as “Individual-1”) who was not seeing him for patient visits in 2023 and 2024, while he also failed to keep medical records for Individual-1 and ignored indications that she was abusing the drug.

Viagrande also admitted to regularly prescribing amphetamine to “Individual-2” at Individual-1’s request, even though Individual-2 was never his patient. Viagrande admitted to ignoring indications that Individual-1 was picking up Individual-2’s prescriptions at pharmacies.

At sentencing, before Senior United States District Judge Frederick J. Scullin, Jr., Viagrande faces up to 20 years in prison and a fine of up to $1 million, as well as at least 3 years of post-imprisonment supervised release. A defendant’s sentence is imposed by a judge based on the particular statute the defendant is charged with violating, the U.S. Sentencing Guidelines and other factors.

As part of his plea agreement, Viagrande surrendered his DEA registration, which had allowed him to prescribe controlled substances.

The DEA’s Tactical Diversion Squad (TDS) investigated this case. TDS is comprised of DEA Special Agents and Diversion Investigators, as well as Investigators from the New York State Department of Health, Bureau of Narcotic Enforcement. Assistant U.S. Attorney Michael Barnett is prosecuting this case.